IP Library Granted Patent US 7,354,902
Granted Patent B2
US 7,354,902 · App. 10/446,234 · Granted Apr 8, 2008

Recombinant lactoferrins, methods of production from plants and uses thereof

Assignee: Meristem Therapeutics S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,354,902
App. No.
10/446,234
Granted
Apr 8, 2008
Kind
B2
Abstract

The invention concerns the use of a recombinant nucleotide sequence containing a cDNA coding for a lactoferrin, in particular human lactoferrin, or the derived proteins, and elements enabling a plant cell to produce lactoferrin or the derived proteins, coded by said cDNA, in particular a transcription promoter and terminator identified by the plant cell transcription machinery, to transform plant cells in order to obtain, from these cells, or plants obtained therefrom, lactoferrin or derived proteins.

Claims (39)

1. A mature lactoferrin obtained by a method of producing lactoferrin comprising:

(a) transforming plant cells so as to integrate a recombinant nucleotide sequence within the genome of the plant cells, the plant cells selected from the group consisting of maize, wheat, barley and rice cells, and the recombinant nucleotide sequence comprising:

(i) a coding sequence for the mature lactoferrin,

(ii) a transcription promoter and terminator which are operably linked to the coding sequence of (i) and are recognized by transcriptional machinery of plant cells, and

(iii) a coding sequence for a signal peptide that directs secretion of recombinant peptides from plant cells,

(b) expressing lactoferrin in said transformed plant cells, and

(c) recovering the lactoferrin expressed in said transformed plant cells, wherein the expressed lactoferrin is mature lactoferrin.

2. The lactoferrin of claim 1 , wherein the coding sequence for the lactoferrin is a coding sequence for human lactoferrin.

3. The lactoferrin of claim 1 , wherein the coding sequence for a signal peptide is a sequence selected from the group consisting of a coding sequence for a signal peptide of lactoferrin, a coding sequence for the signal peptide of sweet potato sporamin A and a coding sequence for PRS (pathogenesis related protein).

4. The lactoferrin of claim 1 , wherein the terminator is selected from the group consisting of the terminator polyA 35S of the CaMV (cauliflower mosaic virus), and the terminator polyA NOS of Agrobacterium tumefaciens and is located downstream of the coding sequence for the mature lactoferrin.

5. The lactoferrin of claim 1 , wherein the transcription promoter is selected from the group consisting of the 35S promoter of the CaMV, the double constitutive promoter of the CaMV, the promoter pCRU of the radish cruciferin gene, the promoters pGA1 and pGA6 of Arabidopsis thaliana , the chimeric promoter super-promoter PSP of Agrobacterium tumefaciens , the rice actin promoter followed by the actin intron PAR-IRA promoter, the wheat HMWG promoter, and the maize gamma-zein promoter.

6. The lactoferrin of claim 1 , wherein the recovering of the recombinant lactoferrin is by extraction followed by purification.

7. The lactoferrin of claim 1 , wherein the transforming of plant cells is by means of Agrobacterium tumefaciens transformed by a vector containing the recombinant sequence.

8. The lactoferrin of claim 1 , wherein:

the coding sequence for the mature lactoferrin is the coding sequence for human lactoferrin,

the coding sequence for a signal peptide is the coding sequence for the signal peptide of sweet potato sporamin A,

the terminator is the terminator polyA 35S of the CaMV, and

the transcription promoter is the wheat HMWG promoter.

9. A biomaterial or a pharmaceutical, medical, odontological, cosmetic or biotechnological composition which comprises the lactoferrin of claim 1 .

10. A mature lactoferrin obtained by a method of producing lactoferrin comprising:

(a) transforming plant cells so as to integrate a recombinant nucleotide sequence within the genome of the plant cells, the plant cells selected from the group consisting of maize, wheat, barley and rice cells, and the recombinant nucleotide sequence comprising:

(i) a coding sequence for the mature lactoferrin,

(ii) a transcription promoter and terminator which are operably linked to the coding sequence of (i) and are recognized by transcriptional machinery of plant cells, and

(iii) a coding sequence for a signal peptide that directs secretion of recombinant peptides from plant cells,

(b) producing transformed plants from the transformed plant cells,

(c) expressing lactoferrin from said transformed plants, and

(d) recovering the lactoferrin expressed from said transformed plants, wherein the expressed lactoferrin is mature lactoferrin.

11. The lactoferrin of claim 10 , wherein the coding sequence for the lactoferrin is a coding sequence for human lactoferrin.

12. The lactoferrin of claim 10 , wherein the coding sequence for a signal peptide is a sequence selected from the group consisting of a coding sequence for a signal peptide of lactoferrin, a coding sequence for the signal peptide of sweet potato sporamin A and a coding sequence for PRS.

13. The lactoferrin of claim 10 , wherein the terminator is selected from the group consisting of the terminator polyA 35S of the CaMV, and the terminator polyA NOS of Agrobacterium tumefaciens and is located downstream of the coding sequence for the mature lactoferrin.

14. The lactoferrin of claim 10 , wherein the transcription promoter is selected from the group consisting of the 35S promoter of the CaMV, the double constitutive promoter of the CaMV, the promoter pCRU of the radish cruciferin gene, the promoters pGA1 and pGA6 of Arabidopsis thaliana , the chimeric promoter super-promoter PSP of Agrobacterium tumefaciens , the rice actin promoter followed by the actin intron PAR-IRA promoter, the wheat HMWG promoter, and the maize gamma-zein promoter.

15. The lactoferrin of claim 10 , wherein the recovering of the recombinant lactoferrin is by extraction followed by purification.

16. The lactoferrin of claim 10 , wherein the transforming of plant cells is by means of Agrobacterium tumefaciens transformed by a vector containing the recombinant sequence.

17. The lactoferrin of claim 10 , wherein:

the coding sequence for the mature lactoferrin is the coding sequence for human lactoferrin,

the coding sequence for a signal peptide is the coding sequence for the signal peptide of sweet potato sporamin A,

the terminator is the terminator polyA 35S of the CaMV, and

the transcription promoter is the wheat HMWG promoter.

18. A biomaterial or a pharmaceutical, medical, odontological, cosmetic or biotechnological composition which comprises the lactoferrin of claim 10 .

Assignments (4)
CHANGE OF NAME Recorded Oct 30, 2023
From: VENTRIA BIOSCIENCE INC.
To: INVITRIA, INC.
Reel/Frame 065394/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2013
From: EDULIS
To: VENTRIA BIOSCIENCE
Reel/Frame 030850/0831 →
MERGER Recorded Jul 19, 2013
From: VENTRIA BIOSCIENCE
To: VENTRIA BIOSCIENCE INC.
Reel/Frame 030842/0308 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2012
From: MERISTEM THERAPEUTICS
To: EDULIS
Reel/Frame 028247/0180 →
Continuity (2)
Division 0942309700
Related Publication 20030229925A1 · Dec 11, 2003